NLM Logo

Pharmacogenomic Testing MeSH Descriptor Data 2025


MeSH Heading
Pharmacogenomic Testing
Tree Number(s)
E01.370.225.562.500
E05.200.562.500
E05.393.435.500
N02.421.308.430.500
N02.421.726.233.221.500
Unique ID
D000071185
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000071185
Scope Note
The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.
Entry Term(s)
Pharmacogenetic Analysis
Pharmacogenetic Screening
Pharmacogenetic Study
Pharmacogenetic Testing
Pharmacogenomic Analysis
Pharmacogenomic Screening
Pharmacogenomic Study
Previous Indexing
Genetic Testing (2001-2016)
Pharmacogenetics (2001-2016)
Public MeSH Note
2017
History Note
2017
Date Established
2017/01/01
Date of Entry
2016/07/05
Revision Date
2016/06/16
Pharmacogenomic Testing Preferred
Pharmacogenomic Analysis Related
page delivered in 0.158s